Key result
A retrospective audit of CHF patients found only 52% were discharged on ACEI/ARBs and 49% on beta-blockers, though prescribing rates were higher in cardiac wards and with pharmacist review.
Why the study?
Does pharmacist review and admission to a cardiac ward improve adherence to evidence-based therapy prescribing for chronic heart failure at discharge?
Observational
No
Does pharmacist review and admission to a cardiac ward improve adherence to evidence-based therapy prescribing for chronic heart failure at discharge?
Adherence to heart failure guidelines remains suboptimal, but admission to cardiac wards and pharmacist review are associated with higher rates of evidence-based therapy prescribing at discharge.
Suboptimal ACEI/ARB and beta-blocker prescribing persists at CHF discharge; leaves open whether cardiac wards or pharmacist review improve adherence.
No takes yet. Share an insight, caveat, or question.
Khalil et al. (2017) conducted an observational in Chronic heart failure (CHF). Evidence-based therapy (EBT) was evaluated on Proportion of patients prescribed evidence-based therapy (EBT) for CHF on discharge. A retrospective audit of CHF patients found only 52% were discharged on ACEI/ARBs and 49% on beta-blockers, though prescribing rates were higher in cardiac wards and with pharmacist review.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: